Fig. 1From: Current evidence for J147 as a potential therapeutic agent in nervous system disease: a narrative reviewChemical structure of J147 [14]. The structure of J147 originated from the hypothetically bioactive fragment of CNB-001 (not shown) [14], with the central pyrazole ring partly replaced by a trifluoroacetamide group, which reduced the molecular weight of CNB-001 and potentially increased its solubilityBack to article page